Genocea Biosciences Inc (OTCPK:GNCAQ)

$ 0.0001 0 (0%) Market Cap: - Enterprise Value: -4.65 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Genocea Biosciences Inc at Needham Healthcare Conference Transcript
Apr 12, 2022
Genocea Biosciences Inc at American Association for Cancer Research (AACR) Investor Webinar Transcript
Apr 08, 2022
Q4 2021 Genocea Biosciences Inc Earnings Call Transcript
Mar 10, 2022

$1.17 (-1.68%)

Earnings
Q3 2021 Genocea Biosciences Inc Earnings Call Transcript
Oct 28, 2021

$1.8 (+7.78%)

Earnings
Q2 2021 Genocea Biosciences Inc Earnings Call Transcript
Jul 29, 2021

$2.04 (+0.49%)

Earnings
Q1 2021 Genocea Biosciences Inc Earnings Call Transcript
Apr 29, 2021

$2.66 (+2.31%)

Earnings
Q4 2020 Genocea Biosciences Inc Earnings Call Transcript
Feb 11, 2021

$3.28 (-2.96%)

Earnings
Genocea Biosciences, Inc. - Special Call Transcript
Nov 09, 2020
Q3 2020 Genocea Biosciences Inc Earnings Call Transcript
Oct 29, 2020

$2.12 (-6.61%)

Earnings
Q2 2020 Genocea Biosciences Inc Earnings Call Transcript
Jul 23, 2020

$3.6 (+14.65%)

Earnings
Genocea Biosciences Inc Annual Shareholders Meeting Transcript
Jun 01, 2020
Genocea Biosciences, Inc. - Shareholder/Analyst Call Transcript
May 12, 2020
Q1 2020 Genocea Biosciences Inc Earnings Call Transcript
Apr 30, 2020

$2.28 (+1.33%)

Earnings
Q4 2019 Genocea Biosciences Inc Earnings Call Transcript
Feb 13, 2020

$2.18 (-3.33%)

Earnings
Q3 2019 Genocea Biosciences Inc Earnings Call Transcript
Oct 24, 2019

$2.45 (-6.49%)

Earnings
Q2 2019 Genocea Biosciences Inc Earnings Call Transcript
Jul 25, 2019

$3.53 (-7.11%)

Earnings
Genocea Biosciences, Inc. - Special Call Transcript
Jun 03, 2019
Q1 2019 Genocea Biosciences Inc Earnings Call Transcript
Apr 30, 2019

$5.6 (-7.89%)

Earnings
Q4 2018 Genocea Biosciences Inc Earnings Call Transcript
Feb 28, 2019

$5.84 (-18.89%)

Earnings

Q2 2019 Genocea Biosciences Inc Earnings Call Transcript

Jul 25, 2019 / 12:30PM GMT

Release Date Price: $3.53 (-7.11%)

Transcript 10-Q8-K

Operator

Good morning, ladies and gentlemen, and welcome to the Genocea Biosciences Second Quarter 2019 Financial Results. (Operator Instructions).

And without further delay, I would like to hand over the program to Mr. Dan Ferry. Sir, you may begin.

Daniel Ferry

LifeSci Advisors, LLC - MD & Relationship Manager

Thank you, operator, and good morning, everyone. Earlier today, we issued a press release that outlines the topics we plan to discuss today. This release is available at genocea.com, under the Investors tab.

During the call today, Chip Clark, President and CEO, will provide a brief corporate update; and the company's Chief Financial Officer, Diantha Duvall, will review the financial results. After the prepared remarks, we'll open up the call for Q&A, and Chip; Diantha; Tom Davis, Genocea's Chief Medical Officer; and Jess Flechtner, Genocea's Chief Scientific Officer, will then be available to answer your questions.

Before we begin, I would like to remind everyone that statements made during this conference call relating to

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.